Merck & Co. Sees $951 Million Trading Volume Amid CDC Vaccine Advisor Controversy Ranking 84th in Market Activity

On June 11, 2025, Merck & Co. (MRK) experienced a trading volume of $951 million, ranking 84th in the day's stock market activity. The company's stock price decreased by 1.27%.

Health and Human Services Secretary Robert F. Kennedy Jr. made a significant move by removing all 17 members of the CDC's Advisory Committee on Immunization Practices. This decision, characterized as a "bold step" to restore public trust in vaccines, has sparked controversy and concern among experts. The removal of these vaccine experts has been criticized for potentially circumventing scientific processes and threatening public health. Kennedy Jr. argued that this action was necessary to rebuild confidence in vaccine safety and efficacy.

Merck & Co., a prominent pharmaceutical company, has been closely monitoring the situation. The company's CEO addressed the removal of the CDC vaccine advisors, highlighting the potential implications for public health and the pharmaceutical industry. The firing of the advisory committee members has raised questions about the future of vaccine policy and the role of scientific expertise in public health decisions.